Available via license: CC BY 4.0
Content may be subject to copyright.
International Journal of
Neonatal Screening
Article
Oxygen Saturation Reference Value by Percutaneous
Pulse Oximetry in Asymptomatic Newborn Babies in
Nigeria: A Cross-Sectional Study
Obumneme Ezeanosike 1, *, Tagbo Oguonu 2, Ngozi Ibeziako 2and Bede Ibe 2
1Department of Paediatrics, Ebonyi State University, Abakaliki 480213, Nigeria
2Department of Paediatrics, University of Nigeria, Enugu Campus, Nsukka 400261, Nigeria;
azunyi@yahoo.com (T.O.); ngozibeziako@yahoo.com (N.I.); chidozieibe76@gmail.com (B.I.)
*Correspondence: ezeanosike.obum@gmail.com; Tel.: +234-803-674-1420
Academic Editor: Peter C.J.I. Schielen
Received: 23 June 2016; Accepted: 12 August 2016; Published: 18 August 2016
Abstract:
About 1/4 of all neonatal deaths in Nigeria are caused by birth asphyxia. Normal values
of oxygen saturation vary according to regional altitudes. They are important for the screening
of cyanotic congenital heart diseases and during newborn resuscitation. There is a dearth of such
information in Nigeria. We determined reference values for oxygen saturation by pulse oximetry
(SpO
2
) in asymptomatic newborns aged
≤
7 days in Enugu at an altitude of 180 m. The study was
cross-sectional. Neonates weighing
≥
1500 g at birth were enrolled consecutively. Pre-and post-ductal
oxygen saturation was measured using a Datex-Ohmeda Tuffsat
®
pulse oximeter with neonatal
probes. Five hundred and fourteen babies comprising of 24 (4.4%) preterm and 490 (95.3%) term
neonates were studied. The mean pre-ductal SpO
2
of all babies was 96.1%
±
1.4% and higher than
mean post-ductal SpO
2
of 95.9%
±
1.4% (p= 0.022). The mean pre-ductal SpO
2
were 96.1%
±
1.5%
and 96.1%
±
1.3%, (p= 1.000) for males and females, respectively. The mean pre-ductal SpO
2
values
were higher than the mean post-ductal SpO2for the corresponding post-natal ages.
Keywords: newborn babies; oxygen saturation; pulse oximetry; reference value
1. Introduction
Pulse oximetry offers a reliable, non-invasive, real-time, and objective method for monitoring
oxygen saturation, and has been found to be very useful even in dark-skinned populations where
cyanosis is often difficult to recognize with naked eyes only [
1
–
3
]. Additionally, assessing skin
colour for cyanosis is difficult, and skin colour is a poor proxy for tissue oxygenation during
the first few minutes of life [
4
]. The efficacy and sensitivity of pulse oximetry in assessing the
cardiopulmonary adaptation of the newborn, both in normal and asphyxiated newborn infants at birth
is well documented [
4
–
8
]. Dawson et al. showed in their review that during the first few minutes
of life, oxygen saturation (saturation by pulse oximetry, SpO
2
) increases from intrapartum levels of
30%–40% to normal values [
4
,
9
,
10
], and advocated that for routine use of pulse oximetry in the delivery
room, more research was needed to define normoxia so as to properly apply SpO
2
readings to clinical
practice to improve short-term and long-term outcomes [
4
]. The American Academy of Pediatrics
(AAP) and the World Health Organization (WHO) recommend that the assessment following positive
pressure ventilation during neonatal resuscitation should consist of simultaneous evaluation of three
(3) vital characteristics: heart rate, respirations, and the state of oxygenation—the latter optimally
determined by a pulse oximeter [
11
–
13
]. Other recommendations for use of the pulse oximeter include
when cyanosis is persistent or when supplementary oxygen is administered. This helps to monitor
if babies achieve age-related targets of oxygen saturation. It is therefore important to have reference
Int. J. Neonatal Screen. 2016,2, 6; doi:10.3390/ijns2030006 www.mdpi.com/journal/neonatalscreening
Int. J. Neonatal Screen. 2016,2, 6 2 of 8
values for these targets [
12
]. Clinical guidelines suitable for settings with limited resources based on
the reference values of oxygen saturation will be very important for effective and efficient use of the
pulse oximeter during resuscitation at birth [14].
These have been established in many other countries [
15
–
17
]. Lozano et al. [
15
] published a study
on the reference values of pulse oximetry for children aged 5 days to 24 months and living at Bogota at
an altitude of 2640 m above sea level. They found that the values were normally distributed with a
mean (SD) of 93.3% and 95% confidence intervals (CI) of 93.0% to 93.6%. Bakr et al. [
16
] also studied
oxygen saturation of term newborns at birth, one hour, and at 24 h at an altitude of 1640 m above sea
level. They showed that these values were significantly lower than those at sea level (94.3% SpO
2
at one
hour of birth and 95.4% at 24 h of birth). Balasubramanian et al. [17] determined the reference values
for children between 1 month and 5 years in India living at sea level. They showed the reference value
for mean of SpO
2
in those healthy children to be 98.5% with a
−
2SD of 96.6%. However, the values
from these countries apply to the regions where they were determined with their specific geography,
such as altitude and atmospheric pressure [15–17].
Knowing well that oximeter performance deteriorates with increasing skin pigmentation [
18
,
19
]
and that our region is predominantly dark skinned, and also knowing that there are no reference
values for oxygen saturation in our environment, it becomes expedient to determine the reference
values for oxygen saturation to guide pulse oximeter use in this environment.
This study was carried out to determine the reference values for pre- and post-ductal oxygen
saturation using pulse oximetry in asymptomatic newborns aged 0–7 days in Enugu, a city at an
altitude of 180 m above sea level in southeast Nigeria [20].
2. Materials and Methods
This was a cross-sectional, observational study carried out in the post-natal wards of three
hospitals in the city of Enugu, Nigeria. These were, University of Nigeria Teaching Hospital, Ituku
Ozalla, Enugu State University Teaching Hospital, and the Mother of Christ Specialist Hospital,
Enugu, southeast Nigeria between July 2007 and June 2008. These hospitals offer regular obstetric
and paediatric care to residents of Enugu and its environs. Consecutive healthy newborn babies aged
0–168 h, weighing
≥
1500 g at birth, and whose parents gave informed consent were enrolled. No baby
was enrolled more than once during the study. Single measurements of the pre- and post-ductal oxygen
saturation of the newborns were taken using a Datex-Ohmeda Tuffsat
®
hand-held pulse oximeter
with a re-usable arterial oxygen saturation sensor, Ameritus
®
E203-02 Flex-Site SpO
2
neonatal sensor.
The neonatal sensor probe was connected to the pulse oximeter before being applied to the newborn at
the ulnar border of the right palm. A post ductal pulse oximetry reading was obtained immediately
afterwards with the sensor applied to the foot on the same subject. Newborn babies were allowed
at least 10 min immediately after delivery to undergo post-natal transition before applying probes,
as there are age-related differences (in minutes) in normal target values of oxygen saturation [
12
,
21
].
Analysis was done with Statistical Package for Social Sciences (version 16.0.; SPSS Inc., Chicago, IL,
USA). Means and standard deviations were determined as appropriate, and differences were tested for
statistical significance using the student t-test. A one-way analysis of variance (ANOVA) was used to
compare means of pre-ductal SpO2between different age groups.
3. Results
Five hundred and fourteen neonates aged 0–7 days were enrolled for the study. There were
249 (48.4%) males and 265 (51.6%) females, giving a male to female ratio of 1:1.1 (See Table 1).
The gestational age (GA) of the population is shown in Table 2, with twenty-four (4.7%) neonates
delivered before 37 completed weeks of gestation, and four hundred and ninety (95.3%) delivered at
term. Other demographic characteristics of the study subjects are shown in Table 3.
Int. J. Neonatal Screen. 2016,2, 6 3 of 8
Table 1. Sex distribution of the study subjects.
Age Group (Hours) Sex Total (N)
Male (%) Female (%)
0–24 58 (23.3) 57 (21.5) 115
25–48 59 (23.7) 61 (23.0) 120
49–72 42 (16.9) 56 (21.1) 98
73–96 47 (18.9) 48 (18.2) 95
97–120 25 (10.0) 20 (7.5) 45
121–144 11 (4.4) 12 (4.5) 23
145–168 7 (2.8) 11 (4.2) 18
Total 249 265 514
Table 2. The gestational age (GA) at birth of the study population.
GA at Birth (Weeks) Number (N, %)
33 1 (0.2)
34 0 (0.0)
35 5 (1.0)
36 18 (3.5)
37 52 (10.1)
38 96 (18.7)
39 160 (31.1)
40 106 (20.6)
41 54 (10.5)
42 22 (4.3)
Total 514 (100.0)
Table 3. Demographic characteristics of the study subjects.
Variable Overall Mean Range Males
(Mean ±SD)
Females
(Mean ±SD) t-Test
GA (weeks) 38.9 ±l.7 33–42 39.1 ±l.7 38.7 ±l 8 2.41
Postnatal age (hours)
60.9 ±39.0 0–168 60.5 ±39.0 61.0 ±39.2 −0.16
Weight (kg) 3.3 ±0.5 2.1–4.4 3.3 ±0.5 3.3 ±0.5 −0.07
Length (cm) 49.1 ±2.2 40–55 49.2 ±2.3 49.1 ±2.1 1.04
* OFC (cm) 34.8 ±2.3 30–38 35.0 ±2.9 34.6 ±1.3 1.75
* OFC = Occipito frontal circumference.
3.1. Pre- and Post-Ductal SpO2of Study Subjects
Table 4shows the pre- and post-ductal SpO
2
of the study subjects. The range of SpO
2
for each of
the two sites was 89%–100%. The overall mean pre-ductal SpO
2
was 96.1%
±
l.4% and was significantly
higher than the overall mean post-ductal SpO
2
of 95.9%
±
1.4% (p= 0.02). The highest mean pre-ductal
SpO
2
percentage was 96.5%
±
1.3% in the 121–144 h age group, while the lowest was 95.4%
±
1.8%
in the 145–168 h age group. The highest mean post-ductal SpO
2
percentage was 96.3%
±
1.4% in the
121–144 h age group, while the lowest was the lowest was 95.3%
±
l.8% in the 145–168 h age group.
For all groups, the mean pre-ductal SpO2were higher than the post-ductal values.
Int. J. Neonatal Screen. 2016,2, 6 4 of 8
Table 4.
Comparison of pre- and post-ductal saturation by pulse oximetry (SpO
2
) of the study subjects.
Age Group
(Hours) Number Mean ±SD
Pre-Ductal SpO2(%)
Mean ±SD
Post-Ductal SpO2(%)
Mean
Difference t-Test p-Value
0–24 115 96.0 ±1.4 95.8 ±1.4 0.20 1.08 0.280
25–48 120 96.0 ±1.2 95.8 ±1.3 0.20 1.24 0.217
49–72 98 96.4 ±1.5 96.0 ±1.5 0.40 1.87 0.063
73–96 95 96.3 ±1.4 96.0 ±1.4 0.30 1.48 0.141
97–120 45 95.9 ±1.4 95.8 ±1.5 0.10 0.33 0.744
121–144 23 96.5 ±1.3 96.3 ±1.4 0.20 0.50 0.618
145–168 18 95.4 ±1.8 95.3 ±1.8 0.10 0.17 0.869
Total 514 96.1 ±1.4 95.9 ±1.4 0.20 2.29 0.022 *
*p-Value is significant if p≤0.05.
3.2. The GA at Birth and Pre-Ductal SpO2
Table 5shows the impact of GA at birth on pre-ductal SpO
2
. The highest SpO
2
of 96.4%
±
1.4%
was seen in neonates delivered at 40 weeks gestation, while the lowest was 95.6%
±
1.0%, seen in the
neonates delivered at 42 weeks gestation.
Table 5. The GA at birth and pre-ductal SpO2.
GA at Birth (Weeks) Number Studied (n) Mean Pre-Ductal SpO2±SD (%)
33 1 96.0
34 - -
35 5 96.1 ±1.5
36 18 95.8 ±1.1
37 52 95.9 ±1.6
38 96 96.3 ±1.3
39 160 96.0 ±1.4
40 106 96.4 ±1.4
41 54 96.0 ±1.3
42 22 95.6 ±1.0
Statistical comparison of the data using ANOVA showed that there was no difference between pre-ductal SpO
2
and GA (F = 0.81, p= 0.61).
3.3. Pre-Ductal SpO2in Relation to Postnatal Age of Infants
Table 6shows a one-way analysis of variance (ANOVA), which was computed to compare the
mean pre-ductal SpO
2
of infants of different postnatal age groups. A small but significant difference
was found among the different postnatal age groups (F= 2.16, p= 0.045, df = 6).
Table 6. Mean values of pre-ductal pulse SpO2in relation to postnatal age of infants.
Age Group
(Hours) nMean Pre-Ductal
SpO2
95% CI
Lower Boundary Upper Boundary
0–24 115 96.0 ±1.4 95.74 96.26
25–48 120 96.0 ±1.2 95.82 96.26
49–72 98 96.4 ±1.5 96.05 96.65
73–96 95 96.3 ±1.4 95.96 96.54
97–120 45 95.9 ±1.4 95.45 96.28
121–144 23 96.5 ±1.3 95.97 97.07
145–168 18 95.4 ±1.8 94.48 96.29
Total 514 96.1 ±1.4 95.99 96.23
A statistical comparison of the data using ANOVA showed that there was a statistically significant difference
between pre-ductal SpO2and post-natal age, (F= 2.16, p= 0.045, df = 6).
Int. J. Neonatal Screen. 2016,2, 6 5 of 8
4. Discussion
The reference value of SpO
2
for asymptomatic newborns aged 0–7 days in the study population
is 96.1%
±
1.4%, and this value represents the overall mean pre-ductal SpO
2
for all study subjects.
It is lower than the reference value of SpO
2
of 98.5% obtained at sea level in Chennai city, India, but
higher than the reference values of SpO
2
of 92.6% and 87.8% obtained at Bogota, Colombia and El Alto,
Bolivia, respectively, which are high altitude regions [
14
–
16
,
21
]. The altitude of a region affects the
oxygen saturation levels. At high altitudes, there is a fall in arterial oxygen saturation which is due to a
reduction in atmospheric oxygen tension. This fall in atmospheric oxygen tension is a consequence of
a fall in barometric pressure at high altitudes [
22
]. The findings in this present study are also consistent
with what Gonzales and Salirrosas obtained in Lima (150 m above sea level), who compared the SpO
2
in healthy newborns delivered at term in Lima to the SpO
2
of neonates delivered in Cerro de Pasco
(4340 m above sea level) and found that at all times, the SpO
2
values were higher at or near sea levels
than at high altitudes [23].
The majority of the deliveries for our study subjects occurred at or near term, and this study did
not demonstrate any significant difference in SpO
2
between neonates delivered preterm and those
delivered at term. The preterm neonates (4.7% of the study subjects) had mean SpO
2
levels of about
96%, which is comparable to those of the term infants. Ng and Subhedar [
24
] showed that healthy
preterm infants maintain a relatively high baseline SpO
2
values. They argued that it is due to the fact
that these preterm infants have a predominance of haemoglobin F (HbF) in their blood, which has a
greater affinity for oxygen than haemoglobin A (HbA) [
24
]. However, Pologe and Raley in a previous
study suggested that the amount of HbF does not have a clinically significant effect on SpO
2
[
25
].
Notably, this study showed lower SpO
2
levels for neonates delivered at 42 completed weeks of gestation
when compared to those delivered earlier. This could possibly be because these infants may have some
compromise due to their GA at birth. More so, these neonates after 42 weeks of gestation mostly likely
will have assisted delivery or Caesarean section, and some studies show that neonates delivered by
Cesarean section have lower SpO
2
values than those delivered vaginally [
26
–
28
], even though this
study did not examine the impact of different modes of delivery on oxygen saturation. This may be
secondary to the delayed clearance of lung fluid during operative delivery without an adequate period
of labour. Other studies found no significant difference in SpO
2
measurements in infants delivered
vaginally or by caesarean section, regardless of the presence or type of anaesthesia [6,29,30].
Postnatally, the mean pre-ductal SpO
2
ranged between 95.4%–96.5% for the first week of life.
Even though the mean SpO
2
on the 3rd, 4th, and 6th days were noted to be higher than that of the
7th day, no definite pattern was noted; rather, one would suggest an overall fairly stable pre-ductal
SpO
2
during this first week of life. This agrees with the pattern of stable or increasing oxygen saturation
reported by Mok, Hak, and McLaughlin in infants at sea level [
31
]. It does, however, differ from the
pattern observed in Han and Tibetan neonates by Niermeyer and co-workers in Lhasa [
32
], Tibet and
also that observed by Niermeyer et al. [
33
] in Colorado infants at 3100 m above sea level. Here, the
oxygen saturation levels fall gradually up to the end of the first week. They suggested that increased
periodic breathing may underlie the fall in SpO
2
observed at one week of life, and this periodic
breathing is increased in infants at high altitudes [
32
,
33
]. Importantly, the SpO
2
on the first day of life
of 96.1%
±
1.4% compares favourably with the saturations on the rest of the days of the first week of
life, in agreement with the findings of a study by O’Brien et al. that during the first day of life, healthy
term infants have baseline SpO
2
values that are very similar to those of older infants with a range from
89%–100% [34].
Studies [
27
,
35
] have documented a difference in oxygen saturation between upper extremity
(pre-ductal) and lower extremity (post-ductal) sites, with lower oxygen saturation seen in the
post-ductal sites. This is similar to the findings in the present study, where the mean pre-ductal
SpO
2
were slightly but consistently higher than the post-ductal values. The observed difference in
the overall mean values of the pre- and post-ductal SpO
2
was statistically significant.
Toth et al. [36]
found in their study that pre-ductal SpO
2
rose more quickly soon after birth to normal values than the
Int. J. Neonatal Screen. 2016,2, 6 6 of 8
post-ductal SpO
2
. This may account for the lower values of post-ductal SpO
2
, especially for values
obtained on the first few days of life. Other factors that may be responsible include better perfusion
of the upper extremities and higher blood pressure and oxygenation in pre-ductal vessels [
28
,
29
].
The process of transitional physiological cyanosis, which can occur during postnatal adaptation,
has also been suggested by Rabi et al. [
28
] to also account for this finding, and this sometimes
manifests clinically as acrocyanosis with bluish coloration of extremities. These healthy babies
undergo a phase of prolonged transitional circulation, and so, the administration of 100% oxygen
to a spontaneously breathing neonate based on visual assessment of cyanosis may be unnecessarily
invasive and can lead to potentially dangerous hyperoxaemia. As ductal-dependent congenital heart
disease may not be apparent at discharge [
37
,
38
], post-ductal arterial pulse oximetry screening during
the first 24 h of life has been shown to be the most useful strategy to prevent circulatory collapse or
death [
39
–
42
]. Therefore, a statistically significant difference between the pre-ductal and post ductal
SpO2in a particular subject should raise the suspicion of a possible critical congenital cardiovascular
disease [
43
–
46
]. However, such values of pulse oximetry for both upper and lower limbs should be
obtained simultaneously. A two-dimensional echocardiograph will be required to confirm or rule out
such suspicions. The pre- and post-ductal oximetry in our subjects were not obtained simultaneously,
but within minutes of each other. Merberg et al., however, showed in their recent study that first day
of life post-ductal pulse oximetry screening will promote early detection of critical congenital heart
diseases with high sensitivity and low false positive rate [
47
]. Additionally,
de Wahl Granelli et al.
,
in a prospective screening study designed to evaluate the use of pulse oximetry in screening for
early detection of life-threatening congenital heart disease, showed that introducing pulse oximetry
screening before discharge improved total detection rate of duct-dependent circulation to 92%, and
would at long-term be a cost-effective procedure if adopted routinely [41].
5. Conclusions
We suggest the reference value for oxygen saturation in newborn babies in Nigeria to be
96.1% ±1.4%
and
95.9% ±1.4%
(pre- and post-ductal, respectively). Measurement of SpO
2
is useful
in routine monitoring of oxygen saturation, which should be done even in resource-limited countries
to minimize the risk of hyperoxaemia, hypoxaemia, or fluctuations between both.
Author Contributions:
Obumneme Ezeanosike and Bede Ibe conceived and designed the study; Obumneme
Ezeanosike performed the experiments; Tagbo Oguonu and Ngozi Ibeziako reviewed and analysed the data;
Ngozi Ibeziako contributed materials and analysis tools; Obumneme Ezeanosike and Tagbo Oguonu wrote
the paper.
Conflicts of Interest: The authors declare no conflict of interest.
References
1.
Tin, W.; Lal, M. Principles of pulse oximetry and its clinical application in neonatal medicine. Semin. Fetal
Neonatal Med. 2015,20, 192–197. [CrossRef] [PubMed]
2.
World Health Organization. Pulse Oximetry Training Manual; WHO Press, World Health Organization:
Geneva, Switzerland, 2011.
3. Fearnley, S.J. Pulse Oximetry. Update in Anaesthesia 1995,5.
4.
Dawson, J.A.; Davis, P.G.; O’Donnell, C.P.; Kamlin, C.O.; Morley, C.J. Pulse oximetry for monitoring infants
in the delivery room: A review. Arch. Dis. Child Fetal Neonat. Ed. 2007,92, F4–F7. [CrossRef] [PubMed]
5.
O’Donnell, C.P.; Kamlin, C.O.; Davis, P.G.; Carlin, J.B.; Morley, C.J. Clinical assessment of infant colour at
delivery. Arch. Dis. Child Fetal Neonat. Ed. 2007,92, F465–F467. [CrossRef] [PubMed]
6.
Dimich, I.; Singh, P.P.; Adell, A.; Hendler, M.; Sonnenklar, N.; Jhaveri, M. Evaluation of oxygen saturation
monitoring by pulse oximetry in neonates in the delivery system. Can. J. Anaesth.
1991
,38, 985–988.
[CrossRef] [PubMed]
7.
Di Fiore, J.M. Neonatal cardiorespiratory monitoring techniques. Semin. Neonatol.
2004
,9, 195–203.
[CrossRef] [PubMed]
Int. J. Neonatal Screen. 2016,2, 6 7 of 8
8.
Rao, R.; Ramji, S. Pulse oximetry in asphyxiated newborns in the delivery room. Indian Pediatr.
2001
,38,
762–766. [PubMed]
9.
Dawson, J.A.; Kamlin, C.O.; Vento, M.; Wong, C.; Cole, T.J.; Donath, S.M.; Davis, P.G.; Morley, C.J. Defining
the reference range for oxygen saturation for infants after birth. Pediatrics
2010
,125, e1340–e1347. [CrossRef]
[PubMed]
10.
East, C.E.; Colditz, P.B.; Begg, L.M.; Brennecke, S.P. Update on intrapartum fetal pulse oximetry. Aust. N. Z.
J. Obstet. Gynaecol. 2002,42, 119–124. [CrossRef] [PubMed]
11.
Kemper, A.R.; Mahle, W.T.; Martin, G.R.; Cooley, W.C.; Kumar, P.; Morrow, W.R.; Kelm, K.; Pearson, G.D.;
Glidewell, J.; Grosse, S.D.; et al. Strategies for implementing screening for critical congenital heart disease.
Pediatrics 2011,128, e1259–e1267. [CrossRef] [PubMed]
12.
NRP Neonatal Resuscitation Textbook 6th Edition (English Version); American Academy of Pediatrics: Chicago,
IL, USA, 2011; p. 345.
13.
World Health Organization. WHO|Pulse Oximetry. Available online: http://www.who.int/patientsafety/
safesurgery/pulse_oximetry/en/ (accessed on 25 August 2015).
14.
Gamponia, M.J.; Babaali, H.; Yugar, F.; Gilman, R.H. Reference values for pulse oximetry at high altitude.
Arch. Dis. Child 1998,78, 461–465. [CrossRef] [PubMed]
15.
Lozano, J.M.; Duque, O.R.; Buitrago, T.; Behaine, S. Pulse oximetry reference values at high altitude.
Arch. Dis. Child 1992,67, 299–301. [CrossRef] [PubMed]
16.
Bakr, A.F.; Habib, H.S. Normal values of pulse oximetry in newborns at high altitude. J. Trop. Pediatr.
2005
,
51, 170–173. [CrossRef] [PubMed]
17.
Balasubramanian, S.; Suresh, N.; Ravichandran, C.; Dinesh Chand, G.H. Reference values for oxygen
saturation by pulse oximetry in healthy children at sea level in chennai. Ann. Trop. Paediatr.
2006
,26, 95–99.
[CrossRef] [PubMed]
18. Bickler, P.E.; Feiner, J.R.; Severinghaus, J.W. Effects of skin pigmentation on pulse oximeter accuracy at low
saturation. Anesthesiology 2005,102, 715–719. [CrossRef] [PubMed]
19.
Feiner, J.R.; Severinghaus, J.W.; Bickler, P.E. Dark skin decreases the accuracy of pulse oximeters at low
oxygen saturation: The effects of oximeter probe type and gender. Anesth. Analg.
2007
,105, S18–S23.
[CrossRef] [PubMed]
20. Duckworth, E.H. Enugu-coal town. Niger. Mag. (Niger. Fed. Min. Inf. Cultural Division) 1961,70, 251.
21.
Poets, C.F.; Stebbens, V.A.; Lang, J.A.; O’Brien, L.M.; Boon, A.W.; Southall, D.P. Arterial oxygen saturation in
healthy term neonates. Eur. J. Pediatr. 1996,155, 219–223. [CrossRef] [PubMed]
22.
Pollard, A.J. Pulse oximetry reference values at high altitude. Arch. Dis. Child
1992
,67, 1413. [CrossRef]
[PubMed]
23.
Gonzales, G.F.; Salirrosas, A. Arterial oxygen saturation in healthy newborns delivered at term in cerro de
pasco (4340 m) and lima (150 m). Reprod. Biol. Endocrinol. 2005,3, 46. [CrossRef] [PubMed]
24.
Ng, A.; Subhedar, N.; Primhak, R.A.; Shaw, N.J. Arterial oxygen saturation profiles in healthy preterm
infants. Arch. Dis. Child Fetal Neonatal Ed. 1998,79, F64–F66. [CrossRef] [PubMed]
25.
Pologe, J.A.; Raley, D.M. Effects of fetal hemoglobin on pulse oximetry. J. Perinatol.
1987
,7, 324–326.
[PubMed]
26.
Harris, A.P.; Sendak, M.J.; Donham, R.T. Changes in arterial oxygen saturation immediately after birth in the
human neonate. J. Pediatr. 1986,109, 117–119. [CrossRef]
27.
Kamlin, C.O.; O’Donnell, C.P.; Davis, P.G.; Morley, C.J. Oxygen saturation in healthy infants immediately
after birth. J. Pediatr. 2006,148, 585–589. [CrossRef] [PubMed]
28.
Rabi, Y.; Yee, W.; Chen, S.Y.; Singhal, N. Oxygen saturation trends immediately after birth. J. Pediatr.
2006
,
148, 590–594. [CrossRef] [PubMed]
29.
House, J.T.; Schultetus, R.R.; Gravenstein, N. Continuous neonatal evaluation in the delivery room by pulse
oximetry. J. Clin. Monit. 1987,3, 96–100. [CrossRef] [PubMed]
30.
Porter, K.B.; Goldhamer, R.; Mankad, A.; Peevy, K.; Gaddy, J.; Spinnato, J.A. Evaluation of arterial oxygen
saturation in pregnant patients and their newborns. Obstet. Gynecol.
1988
,71, 354–357. [CrossRef] [PubMed]
31.
Mok, J.Y.; Hak, H.; McLaughlin, F.J.; Pintar, M.; Canny, G.J.; Levison, H. Effect of age and state of wakefulness
on transcutaneous oxygen values in preterm infants: A longitudinal study. J. Pediatr.
1988
,113, 706–709.
[CrossRef]
Int. J. Neonatal Screen. 2016,2, 6 8 of 8
32.
Niermeyer, S.; Yang, P.; Shanmina; Drolkar; Zhuang, J.; Moore, L.G. Arterial oxygen saturation in Tibetan
and Han infants born in Lhasa, Tibet. N. Engl. J. Med. 1995,333, 1248–1252. [CrossRef] [PubMed]
33.
Niermeyer, S.; Shaffer, E.M.; Thilo, E.; Corbin, C.; Moore, L.G. Arterial oxygenation and pulmonary arterial
pressure in healthy neonates and infants at high altitude. J. Pediatr. 1993,123, 767–772. [CrossRef]
34.
O’Brien, L.M.; Stebbens, V.A.; Poets, C.F.; Heycock, E.G.; Southall, D.P. Oxygen saturation during the first
24 h of life. Arch. Dis. Child Fetal Neonatal Ed. 2000,83, F35–F38. [CrossRef] [PubMed]
35.
Meier-Stauss, P.; Bucher, H.U.; Hurlimann, R.; Konig, V.; Huch, R. Pulse oximetry used for documenting
oxygen saturation and right-to-left shunting immediately after birth. Eur. J. Pediatr.
1990
,149, 851–855.
[CrossRef] [PubMed]
36.
Toth, B.; Becker, A.; Seelbach-Gobel, B. Oxygen saturation in healthy newborn infants immediately after
birth measured by pulse oximetry. Arch. Gynecol. Obstet. 2002,266, 105–107. [CrossRef] [PubMed]
37.
Wren, C.; Richmond, S.; Donaldson, L. Presentation of congenital heart disease in infancy: Implications for
routine examination. Arch. Dis. Child Fetal Neonatal Ed. 1999,80, F49–F53. [CrossRef] [PubMed]
38.
Mellander, M.; Sunnegardh, J. Failure to diagnose critical heart malformations in newborns before
discharge—An increasing problem? Acta Paediatr. 2006,95, 407–413. [CrossRef] [PubMed]
39.
Thangaratinam, S.; Daniels, J.; Ewer, A.K.; Zamora, J.; Khan, K.S. Accuracy of pulse oximetry in screening for
congenital heart disease in asymptomatic newborns: A systematic review. Arch. Dis. Child Fetal Neonatal Ed.
2007,92, F176–F180. [CrossRef] [PubMed]
40.
Arlettaz, R.; Bauschatz, A.S.; Monkhoff, M.; Essers, B.; Bauersfeld, U. The contribution of pulse oximetry
to the early detection of congenital heart disease in newborns. Eur. J. Pediatr.
2006
,165, 94–98. [CrossRef]
[PubMed]
41.
De-Wahl Granelli, A.; Wennergren, M.; Sandberg, K.; Mellander, M.; Bejlum, C.; Inganas, L.; Eriksson, M.;
Segerdahl, N.; Agren, A.; Ekman-Joelsson, B.M.; et al. Impact of pulse oximetry screening on the detection of
duct dependent congenital heart disease: A swedish prospective screening study in 39,821 newborns. BMJ
2009,338, a3037. [CrossRef] [PubMed]
42.
Koppel, R.I.; Druschel, C.M.; Carter, T.; Goldberg, B.E.; Mehta, P.N.; Talwar, R.; Bierman, F.Z. Effectiveness
of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics
2003
,111,
451–455. [CrossRef] [PubMed]
43.
Center for Disease Control and Prevention. Pulse oximetry screening for critical congenital heart defects.
Available online: http://www.cdc.gov/features/congenitalheartdefects/ (accessed on 7 July 2016).
44.
Maheshwari, S. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn
babies: A systematic review and meta-analysis. Indian Heart J. 2012,64, 616. [CrossRef]
45.
Ewer, A.K. Review of pulse oximetry screening for critical congenital heart defects in newborn infants.
Curr. Opin. Cardiol. 2013,28, 92–96. [CrossRef] [PubMed]
46.
New York State Department of Health. Pulse Oximetry Screening for Critical Congenital Heart Disease
(CCHD) Publication 205–2055_4c.Pdf. Available online: https://www.health.ny.gov/publications/2055_4c.
pdf (accessed on 7 July 2016).
47.
Meberg, A.; Brugmann-Pieper, S.; Due, R., Jr.; Eskedal, L.; Fagerli, I.; Farstad, T.; Froisland, D.H.; Sannes, C.H.;
Johansen, O.J.; Keljalic, J.; et al. First day of life pulse oximetry screening to detect congenital heart defects.
J. Pediatr. 2008,152, 761–765. [CrossRef] [PubMed]
©
2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).